PIN1 and melanoma: Together, these independent ex vivo assays, using fresh patient-derived metastatic melanoma slices or 3D melanoids, show that direct inhibition of the Pin1-FOXM1 interaction can be used to repress FOXM1 activity and malignant melanoma proliferation, the latter of which is applicable to complement BRAF inhibition.